The table below shows Spyre Therapeutics, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$0.00
$0.00
$886.00K
$2.33M
$18.74M
$0.00
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
-
-
-
$58.58M
$57.07M
$59.64M
SG&A
$47.91M
SYRE annual revenue (10-K history)
Spyre Therapeutics, Inc. reported annual revenue of $0.00 for fiscal year 2025. Over the 10 fiscal years shown, annual revenue declined from $4.63M (FY 2016) to $0.00. Figures come from the company's audited annual reports as filed with the SEC.